<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03300011</url>
  </required_header>
  <id_info>
    <org_study_id>2014ZDSYLL120.1</org_study_id>
    <nct_id>NCT03300011</nct_id>
  </id_info>
  <brief_title>Ultrasonic Cardiogram Evaluate the Prognosis of Percutaneous Revascularization of Chronic Total Occlusions</brief_title>
  <official_title>Ultrasonic Cardiogram to Evaluate the Long-term Outcome and Prognosis of Coronary Artery Chronic Total Occlusions for Percutaneous Revascularization Versus Optimal Medical Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic total occlusions (CTO) are encountered in almost one-fourth of patients undergoing
      coronary angiography. The presence of an untreated CTO has been related to adverse clinical
      prognosis, both in stable angina and acute myocardial infarction, and is often associated
      with persistent symptomatic angina. Depending on their symptomatic and functional status as
      well as anatomical complexity, CTO can be treated by optimal medical therapy only or therapy
      combined with coronary revascularization. This study designed to evaluate the safety and
      efficacy of coronary chronic total occlusion PCI by ultrasonic cardiogram.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      UCEPPCIOCT maintains a prospective clinical registry of all individual who undergo cardiac
      angiography,PCI or optimistic medicine treatment.

      1. research objective to observe the changes of cardiac function postoperative PCI in
      patients with CTO and the incidence of major adverse cardiovascular events, and provide the
      reality basis for PCI strategy in clinical patients with CTO . 2. research content: follow up
      the patients with CTO by using echocardiography in preoperative and postoperative PCI in 1m,
      3ms, 6ms, 12ms to assess the changes of cardiac structure and cardiac function. 2, comparison
      the `incidence of major adverse cardiovascular events undergo PCI treatment in success and
      failure group in patients with CTO (such as severe angina attack, severe acute coronary
      syndrome, severe heart failure should be rehospitalized , fatal arrhythmia and sudden cardiac
      death, etc.)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2016</start_date>
  <completion_date type="Anticipated">October 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>masking for Ultrasonic Cardiogram investigator</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac death,</measure>
    <time_frame>postoperation 1year</time_frame>
    <description>patients with CTO postoperative sudden death cause for acute myocardial infarction or severe arrhythmia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>postoperation 1year</time_frame>
    <description>recurrent severe angina, revascularization</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Chronic Total Occlusion</condition>
  <arm_group>
    <arm_group_label>recanalisation CTO lesion successful</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with CTO lesion performed PCI strategy and successfully recanalisation the CTO lesion with implanted stents .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>recanalisation CTO lesion failure</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with CTO lesion performed PCI strategy and failure recanalisation the CTO lesion with PCI wire and balloon..</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OMT</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with CTO lesion optimal medicine treatment without PCI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stent</intervention_name>
    <description>PTCA or PCI</description>
    <arm_group_label>recanalisation CTO lesion successful</arm_group_label>
    <other_name>Balloon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        coronary artery of chronic total occlusion

        Exclusion Criteria:

        ACS in 3months; once PCI or CABG; AF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chen Lijuan, Ph.D</last_name>
    <phone>15295583256</phone>
    <email>chenlijuan@seu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ma Genshan, Ph.D</last_name>
    <phone>13002580569</phone>
    <email>magenshan@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weibing Shi, B.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>October 2, 2017</last_update_submitted>
  <last_update_submitted_qc>October 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Genshan Ma</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>ultrasonic</keyword>
  <keyword>chronic total occlusion</keyword>
  <keyword>heart function</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

